cervical cancer
Conditions
Interventions
Group 2:Neoadjuvant Chemotherapy plus Concurrent Chemoradiotherapy
Group 1:Concurrent Chemoradiotherapy alone
Sponsors
The Fourth Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Locally advanced cervical cancer with pathological diagnosis (stage IB2, IIA2, IIB-IVA); 2. Aged 18 to 65 years; 3. PS score 0-1; 4. Estimated survival time is greater than 6 months; 5. Organ functions: white blood cells >=4.0*10^9/L, neutrophils >=1.5*10^9/L; platelets >=100*10^9/L; hemoglobin >=100g/L; Liver function AST and ALT and bilirubin = 60 ml/min.; 6. Can understand the study and has signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Have severe comorbidities or basic diseases; 2. Combine with other malignant tumors; 3. Pregnant women, lactating women; 4. The patient has physical or mental illness, or has no civil capacity or limited capacity for civil conduct.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OS;PFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| AE;ORR;LCR;DMFS; | — |
Countries
China
Contacts
Public ContactCHEN Shaojun
The Fourth Affiliated Hospital of Guangxi Medical University
Outcome results
None listed